EA200970512A1 - Лечение по поводу множественной миеломы - Google Patents
Лечение по поводу множественной миеломыInfo
- Publication number
- EA200970512A1 EA200970512A1 EA200970512A EA200970512A EA200970512A1 EA 200970512 A1 EA200970512 A1 EA 200970512A1 EA 200970512 A EA200970512 A EA 200970512A EA 200970512 A EA200970512 A EA 200970512A EA 200970512 A1 EA200970512 A1 EA 200970512A1
- Authority
- EA
- Eurasian Patent Office
- Prior art keywords
- multiple myeloma
- treatment
- subject
- administering
- treating
- Prior art date
Links
- 208000034578 Multiple myelomas Diseases 0.000 title abstract 2
- 206010035226 Plasma cell myeloma Diseases 0.000 title abstract 2
- 150000001875 compounds Chemical class 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Abstract
Настоящее изобретение относится к способам лечения субъекта, страдающего множественной миеломой, включающим введение субъекту эффективного количества соединения по формуле I:
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US86112006P | 2006-11-27 | 2006-11-27 | |
US90413807P | 2007-02-28 | 2007-02-28 | |
PCT/EP2007/010299 WO2008064866A1 (en) | 2006-11-27 | 2007-11-27 | Treatment for multiple myeloma |
Publications (1)
Publication Number | Publication Date |
---|---|
EA200970512A1 true EA200970512A1 (ru) | 2009-12-30 |
Family
ID=39157918
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EA200970512A EA200970512A1 (ru) | 2006-11-27 | 2007-11-27 | Лечение по поводу множественной миеломы |
Country Status (12)
Country | Link |
---|---|
US (1) | US20100069316A1 (ru) |
EP (1) | EP2139482B1 (ru) |
JP (1) | JP2010510971A (ru) |
KR (1) | KR20090093965A (ru) |
AT (1) | ATE533489T1 (ru) |
AU (1) | AU2007324850A1 (ru) |
CA (1) | CA2669128C (ru) |
EA (1) | EA200970512A1 (ru) |
ES (1) | ES2377717T3 (ru) |
IL (1) | IL198901A0 (ru) |
MX (1) | MX2009005649A (ru) |
WO (1) | WO2008064866A1 (ru) |
Families Citing this family (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EA201291220A1 (ru) | 2010-06-04 | 2013-07-30 | Ф.Хоффманн-Ля Рош Аг | Производные аминопиримидина в качестве модуляторов lrrk2 |
RS59106B1 (sr) | 2010-11-10 | 2019-09-30 | Genentech Inc | Derivati pirazol aminopirimidina kao lrrk2 modulatori |
CA2834414A1 (en) * | 2011-05-02 | 2012-11-08 | Christopher John Burns | Multiple myeloma treatment |
IL289300B1 (en) * | 2012-04-13 | 2024-01-01 | Epizyme Inc | Combined treatment for cancer |
KR101471273B1 (ko) * | 2013-01-29 | 2014-12-11 | 인제대학교 산학협력단 | Sod2를 포함하는 보르테조밉 내성 진단용 바이오 마커 조성물 및 이를 이용한 진단 키트 |
US11066404B2 (en) | 2018-10-11 | 2021-07-20 | Incyte Corporation | Dihydropyrido[2,3-d]pyrimidinone compounds as CDK2 inhibitors |
US11384083B2 (en) | 2019-02-15 | 2022-07-12 | Incyte Corporation | Substituted spiro[cyclopropane-1,5′-pyrrolo[2,3-d]pyrimidin]-6′(7′h)-ones as CDK2 inhibitors |
US11472791B2 (en) | 2019-03-05 | 2022-10-18 | Incyte Corporation | Pyrazolyl pyrimidinylamine compounds as CDK2 inhibitors |
US11919904B2 (en) | 2019-03-29 | 2024-03-05 | Incyte Corporation | Sulfonylamide compounds as CDK2 inhibitors |
WO2020223469A1 (en) | 2019-05-01 | 2020-11-05 | Incyte Corporation | N-(1-(methylsulfonyl)piperidin-4-yl)-4,5-di hydro-1h-imidazo[4,5-h]quinazolin-8-amine derivatives and related compounds as cyclin-dependent kinase 2 (cdk2) inhibitors for treating cancer |
US11447494B2 (en) | 2019-05-01 | 2022-09-20 | Incyte Corporation | Tricyclic amine compounds as CDK2 inhibitors |
JP2023509260A (ja) | 2019-08-14 | 2023-03-08 | インサイト・コーポレイション | Cdk2阻害剤としてのイミダゾリルピリミジニルアミン化合物 |
AR120184A1 (es) | 2019-10-11 | 2022-02-02 | Incyte Corp | Aminas bicíclicas como inhibidoras de la cdk2 |
US11976073B2 (en) | 2021-12-10 | 2024-05-07 | Incyte Corporation | Bicyclic amines as CDK2 inhibitors |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7618630B2 (en) * | 1998-09-14 | 2009-11-17 | Board Of Regents, The University Of Texas System | Methods of treating multiple myeloma and myeloma-induced bone resorption using integrin antagonists |
US7129242B2 (en) * | 2000-12-06 | 2006-10-31 | Signal Pharmaceuticals, Llc | Anilinopyrimidine derivatives as JNK pathway inhibitors and compositions and methods related thereto |
EP1364949A4 (en) * | 2001-02-02 | 2005-11-23 | Takeda Pharmaceutical | INHIBITOR OF JNK |
US6864047B2 (en) * | 2001-03-29 | 2005-03-08 | Mayo Foundation For Medical Education And Research | IL1-β: a new target for myeloma therapy |
CA2446864C (en) * | 2001-05-16 | 2011-02-15 | Vertex Pharmaceuticals Incorporated | Inhibitors of src and other protein kinases |
-
2007
- 2007-11-27 WO PCT/EP2007/010299 patent/WO2008064866A1/en active Application Filing
- 2007-11-27 EP EP07846860A patent/EP2139482B1/en active Active
- 2007-11-27 KR KR1020097010875A patent/KR20090093965A/ko not_active Application Discontinuation
- 2007-11-27 ES ES07846860T patent/ES2377717T3/es active Active
- 2007-11-27 CA CA2669128A patent/CA2669128C/en not_active Expired - Fee Related
- 2007-11-27 AU AU2007324850A patent/AU2007324850A1/en not_active Abandoned
- 2007-11-27 AT AT07846860T patent/ATE533489T1/de active
- 2007-11-27 EA EA200970512A patent/EA200970512A1/ru unknown
- 2007-11-27 US US12/312,763 patent/US20100069316A1/en not_active Abandoned
- 2007-11-27 JP JP2009537563A patent/JP2010510971A/ja not_active Withdrawn
- 2007-11-27 MX MX2009005649A patent/MX2009005649A/es unknown
-
2009
- 2009-05-21 IL IL198901A patent/IL198901A0/en unknown
Also Published As
Publication number | Publication date |
---|---|
ES2377717T3 (es) | 2012-03-30 |
US20100069316A1 (en) | 2010-03-18 |
MX2009005649A (es) | 2009-06-08 |
CA2669128A1 (en) | 2008-06-05 |
IL198901A0 (en) | 2010-02-17 |
WO2008064866A1 (en) | 2008-06-05 |
AU2007324850A2 (en) | 2009-07-02 |
WO2008064866A8 (en) | 2008-10-02 |
EP2139482B1 (en) | 2011-11-16 |
JP2010510971A (ja) | 2010-04-08 |
EP2139482A1 (en) | 2010-01-06 |
ATE533489T1 (de) | 2011-12-15 |
KR20090093965A (ko) | 2009-09-02 |
CA2669128C (en) | 2011-07-12 |
AU2007324850A1 (en) | 2008-06-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EA200970512A1 (ru) | Лечение по поводу множественной миеломы | |
EA201300860A1 (ru) | Кристаллические трипептидные ингибиторы эпоксикетон-протеазы | |
EA201070328A1 (ru) | Соединения триазолопиридина и их применение в качестве ингибиторов ask | |
UA110338C2 (en) | Chemical compounds | |
EA201200917A1 (ru) | Пролекарства ингибиторов плазменного калликреина | |
EA201290677A1 (ru) | Соединения обратного амида в качестве ингибиторов протеиндеацетилазы и способы их применения | |
EA201290919A1 (ru) | Индазольные соединения и их применение | |
EA201200373A1 (ru) | Соединения и композиции в качестве ингибиторов протеинкиназ | |
EA201000895A1 (ru) | Композиции и способы для лечения лизосомных болезней | |
EA201170872A1 (ru) | Ингибиторы протеинкиназы | |
EA201100750A1 (ru) | Замещенные диоксопиперидинилфталимидные производные | |
EA200700851A1 (ru) | Получение и применение бифенил-4-илкарбониламинокислотных производных для лечения ожирения | |
MA32551B1 (fr) | Nouveaux composes utiles pour le traitement de maladies degeneratives et inflammatoires | |
EA201170521A1 (ru) | Новые соединения | |
MX2009009699A (es) | Compuestos amino-5-[4-(difluorometoxi)fenil sustituidos]-5-fenilim idazolona como inhibidores de beta-secretasa. | |
EA201490814A1 (ru) | Лечение злокачественной опухоли ингибиторами tor-киназы | |
TW200744586A (en) | Therapeutic compounds | |
EA201170832A1 (ru) | Пуриновые соединения | |
EA201270752A1 (ru) | Ингибиторы киназы и способ лечения злокачественной опухоли с их помощью | |
EA201391591A1 (ru) | Лечение множественной миеломы | |
EA201170425A1 (ru) | Тетрациклиновые соединения для лечения ревматоидного артрита и связанные с ними способы лечения | |
UA107562C2 (uk) | Спосіб лікування псоріазу | |
EA200900090A1 (ru) | Бензиламины, способ их получения и их применение в качестве противовоспалительных средств | |
MX2010008226A (es) | Derivados de difluorobifenilamida para el tratamiento de hipertension ocular. | |
BRPI0720050A2 (pt) | 6-oxo-1,6-diidropirimidin-2-ilas no tratamento de doenças proliferativas |